Solid forms of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide, compositions thereof and methods of their use
US-2025000860-A1 · Jan 2, 2025 · US
Signal Pharm Llc holds 148 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 148 |
| Recent patents | 3 |
| First publication | Feb 19, 2015 |
| Latest publication | Jan 2, 2025 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-2025000860-A1 · Jan 2, 2025 · US
US-12129237-B2 · Oct 29, 2024 · US
US-2023338370-A1 · Oct 26, 2023 · US
US-2023158035-A1 · May 25, 2023 · US
US-2023119470-A1 · Apr 20, 2023 · US
Representative or frequently cited publications from precomputed assignee stats.
US-2025000860-A1 · Jan 2, 2025 · US
US-12129237-B2 · Oct 29, 2024 · US
US-2023338370-A1 · Oct 26, 2023 · US
US-2023158035-A1 · May 25, 2023 · US
US-2023119470-A1 · Apr 20, 2023 · US
Most common classification codes in this portfolio.
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 141 |
| Chemistry & Metallurgy | 128 |
| Physics | 8 |
| Operations & Transport | 1 |
| Cross-Sectional Technologies | 1 |
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.